Discngine at CCG’s Drug Design Workshops in Cambridge, UK
On November 19, Peter Schmidtke, Product Owner, will participate in CCG’s workshops to present the science and technology behind Discngine’s newest product, 3dpredict/Ab, a cloud-based SaaS platform for ensemble-based antibody structure prediction and liability property calculations.